Otsuka Holdings Co (STU:OS1) Research & Development: €2,019 Mil (TTM As of Mar. 2026)


STU:OS1 Otsuka Holdings Co Ltd STU:OS1
86 GF Score
Price €60.00
GF Value €45.23
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Otsuka Holdings Co Research & Development?

Otsuka Holdings Co STU:OS1 +2.56% 86 Research & Development is €2,019 Mil as of Mar. 2026. GuruFocus rates STU:OS1 with a GF Score™ of 86/100 and a GF Value™ of €45.23 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Otsuka Holdings Co's Research & Development for the three months ended in Mar. 2026 was €448 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €2,019 Mil.

Otsuka Holdings Co  (STU:OS1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Otsuka Holdings Co Research & Development Related Terms

Otsuka Holdings Co Research & Development Historical Data

* Premium members only.

The historical data trend for Otsuka Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otsuka Holdings Co Research & Development Chart

Otsuka Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,806.02 1,925.79 1,960.37 1,951.01 1,932.62

Otsuka Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 486.41 507.18 494.07 570.68 447.54
STU:OS1
86GF Score
Otsuka Holdings Co Ltd STU:OS1
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otsuka Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,019 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €2,019 Mil mean?
Otsuka Holdings Co (STU:OS1) has a Research & Development of €2,019 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Otsuka Holdings Co and its competitors.
Is Otsuka Holdings Co's Research & Development too high?
Otsuka Holdings Co's current Research & Development is €2,019 Mil. Overall, Otsuka Holdings Co has a GF Score™ of 86/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's Research & Development compare to LLY and JNJ?
Otsuka Holdings Co's Research & Development of €2,019 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Otsuka Holdings Co and its competitors. Otsuka Holdings Co's current Research & Development is €2,019 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (STU:OS1) is currently considered Significantly Overvalued. The stock's GF Value™ is €45.23, compared to a current price of €60.00 — trading 32.7% above its estimated fair value. The current Research & Development is €2,019 Mil. Otsuka Holdings Co's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Otsuka Holdings Co (STU:OS1), the current Research & Development is €2,019 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Otsuka Holdings Co (STU:OS1) Overvalued in 2026?

Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued. The current stock price of €60.00 is trading 32.7% above its estimated GF Value™ of €45.23. GuruFocus considers Otsuka Holdings Co to be Significantly Overvalued.

Key valuation signals for STU:OS1:

  • Research & Development: €2,019 Mil
  • GF Value™: €45.23 vs. price of €60.00 (32.7% above fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the STU:OS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Otsuka Holdings Co Business Description

Address 2-16-4 Konan, Shinagawa Grand Central Tower, Minato-ku, Tokyo, JPN, 108-8241
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
86GF Score

Get the complete analysis for STU:OS1

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€60.00
Price
€45.23
GF Value